Spyre Therapeutics (SYRE) Long-Term Deferred Tax (2022)

Spyre Therapeutics (SYRE) has 1 years of Long-Term Deferred Tax data on file, last reported at $566000.0 in Q4 2022.

• Quarterly Long-Term Deferred Tax changed N/A year-over-year to $566000.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $566000.0 (changed N/A YoY) and the FY2022 annual result came in at $566000.0, changed N/A from the prior year.
• Long-Term Deferred Tax held at $566000.0 in Q4 2022.
• In the past five years, Long-Term Deferred Tax ranged from a high of $566000.0 in Q4 2022 to a low of $566000.0 in Q4 2022.